Dementia with Lewy bodies (DLB) is among the most common causes of degenerative dementia. This book, which represents the first authoritative statement about DLB, includes review articles, case studies, and recent research findings from the leading researchers of DLB. The aims of this volume are to establish clinical diagnostic criteria and pathological protocols for DLB, and to explore evidence indicating that DLB patients may be responsive to symptomatic therapy. Covering the classification, cognitive manifestations, clinical diagnosis, epidemiology, genetics, neuropathology, neurochemistry,…mehr
Dementia with Lewy bodies (DLB) is among the most common causes of degenerative dementia. This book, which represents the first authoritative statement about DLB, includes review articles, case studies, and recent research findings from the leading researchers of DLB. The aims of this volume are to establish clinical diagnostic criteria and pathological protocols for DLB, and to explore evidence indicating that DLB patients may be responsive to symptomatic therapy. Covering the classification, cognitive manifestations, clinical diagnosis, epidemiology, genetics, neuropathology, neurochemistry, and treatment of DLB, this is a landmark publication in clinical neuroscience.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
1. Introduction Part I. Clinical Issues: 2. The clinical diagnosis and misdiagnosis of Lewy body dementia 3. The nosological status of Lewy body dementia 4. Putative clinical and genetic antecedents of dementia associated with Parkinson's disease 5. Clinical features of patients with Alzheimer's disease and Lewy bodies 6. The nature of the cognitive decline in Lewy body dementia 7. Non-cognitive symptoms in Lewy body dementia 8. Hallucinations, cortical Lewy body pathology, cognitive function and neuroleptic use in dementia 9. Neuropsychological aspects of Lewy body dementia 10. The neuroanatomical basis of cognitive deficits in Lewy body dementia 11. The clinical and functional imaging characteristics of Parkinsonian-dementia 12. Positron emission tomography findings in Parkinson's disease and Lewy body dementia 13. Clinical features of diffuse Lewy body disease in the elderly: analysis of 12 cases 14. Senile dementia of Lewy body type - clinical features and prevalence in neuropathological postmortems 15. Lewy body dementia in clinical practice resume of clinical workshop sessions Part II. Pathological Issues: 16. Pathological significance of Lewy bodies in dementia 17. Tautological tangles in neuropathologic criteria for dementias associated with Lewy bodies 18. What is the neuropathological basis of dementia associated with Lewy bodies? 19. Cytoskeletal and Alzheimer-type pathology in Lewy body disease 20. Diffuse Lewy body disease within the spectrum of Lewy body disease 21. Temporal lobe immunohistochemical pathology for tangles, plaques and Lewy bodies in diffuse Lewy body disease, Parkinson's disease and senile dementia of Alzheimer type 22. Pathological and clinical features of Parkinson's disease with and without dementia 23. Dementia with Lewy bodies: relationship to Parkinson's and Alzheimer's diseases 24. What do Lewy bodies tell us about dementia and Parkinsonism? 25. Pathogenesis of the Lewy body 26. Altered tau processing: its role in development of dementia in Alzheimer's disease and Lewy body disease 27. Cytoskeletal pathology in Alzheimer's disease and Lewy body dementia - an epiphenomenon? 28. Genetic correlations in Lewy body disease resume of pathological workshop sessions Part III. Treatment Issues: 29. Psychopharmacology of cognitive impairment in Parkinson's disease 30. Management of the non-cognitive symptoms of Lewy body dementia 31. Altered consciousness and transmitter signalling in Lewy body dementia 32. Cholinergic therapy and Lewy body dementia 33. Clinical heterogeneity in dementia responders to cholinergic therapy 34. Tacrine and symptomatic treatment in Lewy body dementia 35. Neurochemical correlates of pathological and iatrogenic extrapyramidal symptoms 36. Neurotrophins and the cholinergic system in dementia 37. Relevance of Lewy bodies to alterations in oxidative stress in Lewy body dementia and Parkinson's disease Resume of treatment workshop Sessions Appendix.
1. Introduction Part I. Clinical Issues: 2. The clinical diagnosis and misdiagnosis of Lewy body dementia 3. The nosological status of Lewy body dementia 4. Putative clinical and genetic antecedents of dementia associated with Parkinson's disease 5. Clinical features of patients with Alzheimer's disease and Lewy bodies 6. The nature of the cognitive decline in Lewy body dementia 7. Non-cognitive symptoms in Lewy body dementia 8. Hallucinations, cortical Lewy body pathology, cognitive function and neuroleptic use in dementia 9. Neuropsychological aspects of Lewy body dementia 10. The neuroanatomical basis of cognitive deficits in Lewy body dementia 11. The clinical and functional imaging characteristics of Parkinsonian-dementia 12. Positron emission tomography findings in Parkinson's disease and Lewy body dementia 13. Clinical features of diffuse Lewy body disease in the elderly: analysis of 12 cases 14. Senile dementia of Lewy body type - clinical features and prevalence in neuropathological postmortems 15. Lewy body dementia in clinical practice resume of clinical workshop sessions Part II. Pathological Issues: 16. Pathological significance of Lewy bodies in dementia 17. Tautological tangles in neuropathologic criteria for dementias associated with Lewy bodies 18. What is the neuropathological basis of dementia associated with Lewy bodies? 19. Cytoskeletal and Alzheimer-type pathology in Lewy body disease 20. Diffuse Lewy body disease within the spectrum of Lewy body disease 21. Temporal lobe immunohistochemical pathology for tangles, plaques and Lewy bodies in diffuse Lewy body disease, Parkinson's disease and senile dementia of Alzheimer type 22. Pathological and clinical features of Parkinson's disease with and without dementia 23. Dementia with Lewy bodies: relationship to Parkinson's and Alzheimer's diseases 24. What do Lewy bodies tell us about dementia and Parkinsonism? 25. Pathogenesis of the Lewy body 26. Altered tau processing: its role in development of dementia in Alzheimer's disease and Lewy body disease 27. Cytoskeletal pathology in Alzheimer's disease and Lewy body dementia - an epiphenomenon? 28. Genetic correlations in Lewy body disease resume of pathological workshop sessions Part III. Treatment Issues: 29. Psychopharmacology of cognitive impairment in Parkinson's disease 30. Management of the non-cognitive symptoms of Lewy body dementia 31. Altered consciousness and transmitter signalling in Lewy body dementia 32. Cholinergic therapy and Lewy body dementia 33. Clinical heterogeneity in dementia responders to cholinergic therapy 34. Tacrine and symptomatic treatment in Lewy body dementia 35. Neurochemical correlates of pathological and iatrogenic extrapyramidal symptoms 36. Neurotrophins and the cholinergic system in dementia 37. Relevance of Lewy bodies to alterations in oxidative stress in Lewy body dementia and Parkinson's disease Resume of treatment workshop Sessions Appendix.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
